MedTrace Logo

Effectiveness of Ultrasound (US) Guided Supraclavicular Block

NCT00923494 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-01-20

No results posted yet for this study

Summary

This research study is being done in order to find out if there is any difference in the effectiveness of ultrasound guided supraclavicular brachial plexus nerve block that can be achieved with 3 different amounts of ropivacaine 0.5% (20 ml, 30 ml, and 40 ml). The investigators want to show if you can have a successful nerve block with less amount of local anesthetic, thus potentially decreasing the risk of side effects.

Conditions

Interventions

DRUG

20 ml of ropivacaine 0.5%

Patient will receive 20 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.

DRUG

30 ml of ropivacaine 0.5%

Patient will receive 30 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.

DRUG

40 ml of ropivacaine 0.5%

Patient will receive 40 ml of ropivacaine 0.5% for their ultrasound guided supraclavicular block.

Sponsors & Collaborators

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Jaime Ortiz, MD · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00923494 on ClinicalTrials.gov